Company intelligence / Profile preview

SnapCyte Solutions

Vancouver, British Columbia, Canadasnapcyte.com ↗

Ownership: Private
Development stage: Commercial

Overview

SnapCyte Solutions has developed and commercialized an AI-powered platform for automated, accurate, and accessible image-based analysis of cell cultures. Their technology enables real-time assessment of cell confluency, growth, fitness, migration, and morphology using smartphone applications integrated with proprietary deep learning models. The platform is designed to be low-cost and user-friendly for life science researchers without requiring coding or advanced AI expertise

Industry: Drug Discovery Services

Partnerships

MitacsEntrepreneurship@UBCCollaborations with leading academic institutions including University of British Columbia

Beyond the preview

Go deeper on SnapCyte Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SnapCyte Solutions.

Explore the full profile